MedPath

IGNITE Firefighters' Health

Not Applicable
Recruiting
Conditions
Microbiome
Immune Function
Cancer
Inflammation
Registration Number
NCT06567561
Lead Sponsor
Stanford University
Brief Summary

Investigators hope to learn about potential dietary intervention strategies (specifically a whole-food, plant-based diet) that may help lower cancer markers in firefighters.

Detailed Description

The purpose of the San Francisco (SF) Firefighter's Diet Study is to determine if a diet low in processed foods, mostly plant-based, with added fermented foods, can lower the risk of cancer in firefighters. We will assess this by randomly assigning SF firefighters to either a whole-food, plant-based diet or their usual firehouse meals. Participants will be followed for 12 weeks.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Age 18+
  • Active SF firefighter
  • Willing to consume a plant-based diet (vegetables, fruit, whole grains, legumes, etc.)
  • Willing to complete 4 clinic visits
Exclusion Criteria
  • Weight < 110 lb

  • BMI >= 40

  • Self-reported uncontrolled hypercholesterolemia, hypertension or diabetes

  • Pregnant, lactating, or planning to become pregnant during the course of the study.

  • Use of any of the following drugs/supplements within the last 2 months:

    • systemic antibiotics, antifungals, antivirals, or antiparasitics (intravenous, intramuscular, or oral);
    • corticosteroids (intravenous, intramuscular, oral, nasal or inhaled);
    • cytokines;
    • methotrexate or immunosuppressive cytotoxic agents.
  • Chronic, clinically significant, or unstable (unresolved, requiring ongoing changes to medical management or medication) pulmonary, cardiovascular, gastrointestinal, hepatic or renal functional abnormality, as determined by medical history, Type 1 diabetes, dialysis

  • History of active cancer in the past 3 years except for squamous or basal cell carcinomas of the skin that have been medically managed by local excision

  • Unstable dietary history as defined by major changes in diet during the previous month, where the subject has eliminated or significantly increased a major food group in the diet.

  • Recent history of chronic excessive alcohol consumption defined as more than five 1.5-ounce servings of 80 proof distilled spirits, five 12-ounce servings of beer or five 5-ounce servings of wine per day; or > 14 drinks/week.

  • Any confirmed or suspected condition/state of immunosuppression or immunodeficiency (primary or acquired) including HIV infection, multiple sclerosis, and Graves' disease.

  • Surgery of the GI tract, with the exception of cholecystectomy and appendectomy, in the past five years. Any major bowel resection at any time.

  • Regular/frequent use of smoking or chewing tobacco, e-cigarettes, cigars or other nicotine-containing products

  • Regular use of prescription opiate pain medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Difference in IL-6Baseline and 8 weeks

Difference in the 8-week change from baseline in IL-6 between the whole-food plant-based vs. usual diet groups.

Secondary Outcome Measures
NameTimeMethod
Difference in Protein Carbonyl (protein oxidation)Baseline and 8 weeks

Difference in the 8-week change from baseline in Protein Carbonyl (a measure of protein oxidation) between the whole-food plant-based vs. usual diet groups, using the enzyme-linked immunosorbent assay (ELISA).

Difference in Glyc aBaseline and 8 weeks

Difference in the 8-week change from baseline in Glyc a between the whole-food plant-based vs. usual diet groups.

Difference in C-Reactive Protein (CRP)Baseline and 8 weeks

Difference in the 8-week change from baseline in C-Reactive Protein (CRP) between the whole-food plant-based vs. usual diet groups.

Difference in Interleukin-10 (L-10)Baseline and 8 weeks

Difference in the 8-week change from baseline in Interleukin-10 (IL-10) between the whole-food plant-based vs. usual diet groups.

Difference in Tumor Necrosis Factor-alpha (TNF-alpha)Baseline and 8 weeks

Difference in the 8-week change from baseline in Tumor Necrosis Factor-alpha (TNF-alpha) between the whole-food plant-based vs. usual diet groups.

Difference in Cytokines and Inflammatory ProteinsBaseline and 8 weeks

Difference in the 8-week change from baseline in a panel of cytokines and inflammatory proteins using the NUcleic acid Linked Immuno-Sandwich Assay (NULISA™) between the whole-food plant-based vs. usual diet groups.

Difference in CalprotectinBaseline and 8 weeks

Difference in the 8-week change from baseline in Calprotectin between the whole-food plant-based vs. usual diet groups.

Difference in 8-hydroxy-2'-deoxyguanosine (8-OH-dG)Baseline and 8 weeks

Difference in the 8-week change from baseline in 8-hydroxy-2'-deoxyguanosine (8-OH-dG) between the whole-food plant-based vs. usual diet groups.

Difference in Lipid PeroxidationBaseline and 8 weeks

Difference in the 8-week change from baseline in Lipid Peroxidation between the whole-food plant-based vs. usual diet groups, using the Thiobarbituric acid-reactive substance (TBARS) assay.

Difference in Fasting GlucoseBaseline and 8 weeks

Difference in the 8-week change from baseline in Fasting Glucose between the whole-food plant-based vs. usual diet groups.

Difference in Fasting InsulinBaseline and 8 weeks

Difference in the 8-week change from baseline in Fasting Insulin between the whole-food plant-based vs. usual diet groups.

Difference in Low-Density-Lipoprotein Cholesterol (LDL)Baseline and 8 weeks

Difference in the 8-week change from baseline in Low-Density-Lipoprotein Cholesterol (LDL) between the whole-food plant-based vs. usual diet groups.

Difference in High-Density-Lipoprotein Cholesterol (HDL)Baseline and 8 weeks

Difference in the 8-week change from baseline in High-Density-Lipoprotein Cholesterol (HDL) between the whole-food plant-based vs. usual diet groups.

Difference in Triglycerides (TRGs)Baseline and 8 weeks

Difference in the 8-week change from baseline in Triglycerides (TRGs) between the whole-food plant-based vs. usual diet groups.

Difference in TelomeresBaseline and 8 weeks

Difference in the 8-week change from baseline in Telomeres between the whole-food plant-based vs. usual diet groups.

Difference in Epigenetic AgeBaseline and 8 weeks

Difference in the 8-week change from baseline in Epigenetic Age between the whole-food plant-based vs. usual diet groups, assessed by Epigenetic Clocks.

Difference in Gut Microbiome CompositionBaseline and 8 weeks

Difference in the 8-week change from baseline in Gut Microbiome Composition between the whole-food plant-based vs. usual diet groups, assessed by Metagenomic Sequencing.

Difference in Metabolomic ProfilesBaseline and 8 weeks

Difference in the 8-week change from baseline in Gut Microbiome Composition between the whole-food plant-based vs. usual diet groups, assessed by assessed by Targeted and Untargeted Metabolomics

Difference in 4-hydroxynonenal (HNE)Baseline and 8 weeks

Difference in the 8-week change from baseline in 4-hydroxynonenal (HNE) between the whole-food plant-based vs. usual diet groups.

Difference in body compositionBaseline and 8 weeks

Difference in the 8-week change from baseline in body composition between the whole-food plant-based vs. usual diet groups, as assessed by dual energy x-ray absorptiometry scan (DEXA) scans.

Difference in weightBaseline and 8 weeks

Difference in the 8-week change from baseline in weight between the whole-food plant-based vs. usual diet groups.

Difference in systolic blood pressureBaseline and 8 weeks

Difference in the 8-week change from baseline in systolic blood pressure between the whole-food plant-based vs. usual diet groups.

Difference in diastolic blood pressureBaseline and 8 weeks

Difference in the 8-week change from baseline in diastolic blood pressure between the whole-food plant-based vs. usual diet groups.

Trial Locations

Locations (1)

Stanford University

🇺🇸

Palo Alto, California, United States

Stanford University
🇺🇸Palo Alto, California, United States
Roujheen Sabetan, MPH
Contact
650-736-8577
rsabetan@stanford.edu
Christopher Gardner, PhD
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.